Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Invested Capital (2017 - 2025)

Historic Invested Capital for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $149.0 million.

  • Puma Biotechnology's Invested Capital rose 2797.44% to $149.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $149.0 million, marking a year-over-year increase of 2797.44%. This contributed to the annual value of $137.5 million for FY2024, which is 5719.99% up from last year.
  • As of Q3 2025, Puma Biotechnology's Invested Capital stood at $149.0 million, which was up 2797.44% from $138.7 million recorded in Q2 2025.
  • Over the past 5 years, Puma Biotechnology's Invested Capital peaked at $149.0 million during Q3 2025, and registered a low of -$10.9 million during Q3 2021.
  • Its 5-year average for Invested Capital is $65.7 million, with a median of $60.9 million in 2021.
  • Per our database at Business Quant, Puma Biotechnology's Invested Capital crashed by 30760.31% in 2021 and then surged by 98340.15% in 2022.
  • Over the past 5 years, Puma Biotechnology's Invested Capital (Quarter) stood at -$2.4 million in 2021, then soared by 983.4% to $21.6 million in 2022, then surged by 304.66% to $87.4 million in 2023, then surged by 57.2% to $137.5 million in 2024, then grew by 8.39% to $149.0 million in 2025.
  • Its Invested Capital was $149.0 million in Q3 2025, compared to $138.7 million in Q2 2025 and $142.4 million in Q1 2025.